Search Results
Search results for "Ethan Dintzner"
Results found for "Ethan Dintzner"
- First AMA of 2026: GPCR Pharmacology, Biased Signaling & Mechanistic Clarity
grows, it becomes a searchable extension of Terry’s teaching — designed for repeated exposure rather than
- GPCR Collaboration: From Models to Medicine
in academia or biotech, the future belongs to research groups that can orchestrate ecosystems rather than He treats modeling as part of a continuum rather than a separate discipline.
- Carola Weiss joins InterAx Biotech AG as VP Business Development
Carola Weiss is a Senior Executive with more than 20 years of international experience in the biopharmaceutical
- X4 slashes pipeline, lays off staff just three weeks after netting a $55M PIPE
The move comes less than three weeks after X4 pulled together a $55 million PIPE and amended a loan facility
- Allosteric Binding Data Interpretation in Complex Receptor Systems
In this session, we work through: How allosteric ligands redistribute receptor species rather than displace In allosteric binding data interpretation, the curve reflects state transitions rather than competitive
- Understanding Orthosteric Binding: The Key to Drug Action
Unlocking the Secrets of Orthosteric Binding Understanding why some drugs bind better than others is
- From Switches to Microcircuits: GPCR Biased Signaling and the Future of Drug Discovery
Why GPCR Drug Discovery Is More Complex Than It Looks G protein-coupled receptors (GPCRs) have long occupied and the Microcircuit Model of GPCR Pharmacology Understanding GPCRs as allosteric proteins  rather than
- Illuminating the draggable GPCR-ome
This time with none other than Dr. Bryan Roth There are 10 open tickets available. Get yours now!
- Structural basis of GPCR coupling to distinct signal transducers: implications for biased signaling
determine partner preference; or (iii) the dynamics of GPCR binding to different types of partners rather than
- Terry’s Corner, Celtarys' Leap, and the $7B GPCR Horizon
This is more than review, it’s readiness.
- Dr. Marta Filizola - Dr. GPCR Podcast
GPCR Podcast, we have none other than Dr. Marta Filizola!
- Dr. GPCR Spotlights Revvity’s pHSense™ Internalization Tools
A GPCR Internalization Tool Designed for Real Research Needs Built on more than two decade A GPCR Internalization
- Dr. Juan José Fung - Dr. GPCR Podcast
Our guest is none other than Dr. Juan Jose Fung, Principal Scientist, at GPCR Therapeutics.
- Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with ...
Better known as GPCR, the fruitful research space has led to more than 700 approved drugs over previous
- Unconventional GPCR-PKA Communication in the Hedgehog Pathway
Our first guest speaker is none other than Dr. Ben Myers!
- Orthosteric Binding Experiments: How to Avoid the Most Common Data Pitfalls
Clues that point to true multiple-site binding rather than two-stage GPCR biology: Disrupting G protein If the tracer binds faster than the displacer, early time points exaggerate tracer occupancy and underestimate
- From Failed Experiments to Predictive GPCR Models
Rather than focusing solely on explaining receptor behavior post hoc, his group began developing workflows Carlsson notes that it’s easier to find pharmacologists to run assays than it is to persuade chemists
- Exploring pharmacological inhibition of G q/11 as an analgesic strategy
One potential solution is to develop analgesics that act at targets other than opioid receptors.
- Activation of the human chemokine receptor CX3CR1 regulated by cholesterol
A much smaller conformational change of helix VI upon activation than previously solved class A GPCR-Gi
- Maria’s Travel Blogs: ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025
This Chemistry Tools session was more industry focused than those before, and Maria shared the floor
- Crinetics Pharmaceuticals Expands Executive Team With Appointment Of James Hassard As Chief ...
Hassard is a commercial leader with more than three decades of experience leading sales and marketing
- Nanobodies as Probes and Modulators of Cardiovascular G Protein-Coupled Receptors
In less than a decade, nanobodies, or recombinant single-domain antibody fragments from camelids, have
- Choosing the Right GPCR Calcium Assay Readout for Measuring Receptor Activation
is that aequorin must be introduced into cells through genetic engineering or microinjection rather than event can trigger the release of many calcium ions, generating signals that are often easier to detect than
- How a Failed Experiment Created a Powerful GPCR Imaging Tool
therapeutic benefit Where not  to target to avoid adverse effects Why GPCR Imaging Tools Matter More Than
- Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies
and anxiety, has shown, in the last decade, increasing evidence of its antitumoral properties in more than
- Structures of β 1-adrenergic receptor in complex with Gs and ligands of different efficacies
intermediate state complex comprising β1-AR and nucleotide-free Gs is more stable when binding a full agonist than
- Targeted Therapies to Reduce Side Effects in Modern Drug Development
In fact, it is often costly, frustrating, and tortuous—and more often than not it ends in failure.
- Discovery of 3(2-aminoethyl)-thiazolidine-2,4-diones as a novel chemotype of sigma-1 receptor ligand
Six compounds showed more than 50% displacement of the radioligand at 10 µM concentration with compound
- GPCR Happy Hour – Boston, Sept 2025
GPCR Happy Hour is more than a social event.
- AlphaFold’s Breakthrough in GPCR Research: Revolutionizing Discovery, Yet Awaiting Experimental Proof
AlphaFold2 outperformed homology models, achieving a 60% hit rate for compounds targeting TAAR1, more than

















